Molly S. Moye, MD; Sallyann M. C. King, MD, MSc; Zakiya P. Rice, MD; et al.
free access
JAMA Dermatol. 2015;151(2):137-143. doi:10.1001/jamadermatol.2014.2229
This pretest-posttest study found that patients with atypical mole syndrome have low levels of melanoma-related worry.
Jonathan I. Silverberg, MD, PhD, MPH; Lauren Becker, MD; Mary Kwasny, ScD; et al.
free access
JAMA Dermatol. 2015;151(2):144-152. doi:10.1001/jamadermatol.2014.3059
This case-control study found that moderate to severe pediatric atopic dermatitis may be associated with central obesity and increased systolic blood pressure. See also the Invited Commentary by Davis.
April W. Armstrong, MD, MPH; Mary Ann Johnson, MD; Steven Lin, MD; et al.
free access
has audio
JAMA Dermatol. 2015;151(2):154-160. doi:10.1001/jamadermatol.2014.2299
The direct-access online model results in equivalent improvements in atopic dermatitis clinical outcomes as in-person care. Direct-access online care may represent an innovative model of delivering dermatological services to patients with chronic skin diseases.
-
Audio Author Interview:
Patient-Centered, Direct-Access Online Care for AD (JAMA Dermatology)
Junko Takeshita, MD, PhD; Shuwei Wang, MD; Daniel B. Shin, MS; et al.
free access
JAMA Dermatol. 2015;151(2):161-169. doi:10.1001/jamadermatol.2014.2094
This population-based, cross-sectional study finds psoriasis to be associated with a greater likelihood of uncontrolled hypertension in a dose-dependent manner.
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
free access
JAMA Dermatol. 2015;151(2):170-177. doi:10.1001/jamadermatol.2014.2734
This open-label, nonrandomized, phase 2 clinical trial documents cutaneous adverse effects in most patients receiving cabozantinib therapy.
Caroline G. Watts, MPH; Anne E. Cust, MPH (Hons), PhD; Scott W. Menzies, MBBS, PhD; et al.
free access
JAMA Dermatol. 2015;151(2):178-186. doi:10.1001/jamadermatol.2014.1952
This cost analysis of a high-risk clinic for melanoma finds high societal costs reflecting traveling time and lost productivity, findings useful to help inform health policy for melanoma screening and treatment.
Omer Ibrahim, MD; Misbah Khan, MD; Diana Bolotin, MD, PhD; et al.
free access
JAMA Dermatol. 2015;151(2):187-191. doi:10.1001/jamadermatol.2014.2211
This split-body, randomized clinical trial reports significant improvement in skin texture and roughness/bumpiness but not in baseline erythema after treatment of keratosis pilaris with an 810-nm diode laser.